Page last updated: 2024-10-30

mesalamine and Dermatitis, Allergic Contact

mesalamine has been researched along with Dermatitis, Allergic Contact in 1 studies

Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.

Dermatitis, Allergic Contact: A contact dermatitis due to allergic sensitization to various substances. These substances subsequently produce inflammatory reactions in the skin of those who have acquired hypersensitivity to them as a result of prior exposure.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
van der Valk, H1
Pleijhuis, RG1
Voorbij-Vierstra, CL1
Schuttelaar, MLA1

Other Studies

1 other study available for mesalamine and Dermatitis, Allergic Contact

ArticleYear
Case report: Recall dermatitis at patch-test sites after oral provocation with mesalazine.
    The journal of allergy and clinical immunology. In practice, 2022, Volume: 10, Issue:12

    Topics: Dermatitis, Allergic Contact; Humans; Mesalamine; Patch Tests

2022